NASDAQ:KIDS - OrthoPediatrics Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $55.80
  • Forecasted Upside: 8.77 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$51.30
▼ -0.37 (-0.72%)
1 month | 3 months | 12 months
Get New OrthoPediatrics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KIDS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KIDS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$55.80
▲ +8.77% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for OrthoPediatrics in the last 3 months. The average price target is $55.80, with a high forecast of $62.00 and a low forecast of $48.00. The average price target represents a 8.77% upside from the last price of $51.30.
Buy
The current consensus among 3 contributing investment analysts is to buy stock in OrthoPediatrics. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/21/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/19/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/18/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/6/2021Piper SandlerBoost Price Target$55.00 ➝ $62.00Low
i
10/7/2020BTIG ResearchBoost Price TargetBuy$54.00 ➝ $57.00High
i
8/5/2020Needham & Company LLCBoost Price TargetBuy$49.00 ➝ $57.00High
i
Rating by Michael Matson at Needham & Company LLC
6/16/2020Stifel NicolausBoost Price Target$48.00 ➝ $55.00Low
i
6/8/2020BTIG ResearchBoost Price TargetBuy$48.00 ➝ $54.00High
i
5/14/2020JMP SecuritiesLower Price TargetMarket Outperform$50.00 ➝ $48.00Medium
i
5/6/2020BTIG ResearchReiterated RatingBuy$48.00Medium
i
5/6/2020Needham & Company LLCBoost Price TargetBuy$46.00 ➝ $49.00Low
i
4/3/2020BTIG ResearchLower Price TargetBuy$50.00 ➝ $48.00Medium
i
4/2/2020Needham & Company LLCLower Price TargetBuy$56.00 ➝ $46.00Low
i
3/8/2020BTIG ResearchReiterated RatingBuy$50.00Medium
i
3/6/2020Stifel NicolausBoost Price TargetBuy$44.00 ➝ $50.00Low
i
1/7/2020SunTrust BanksInitiated CoverageBuy$54.00Low
i
12/16/2019Piper Jaffray CompaniesBoost Price TargetOverweight$44.00 ➝ $50.00Low
i
11/8/2019Piper Jaffray CompaniesBoost Price TargetOverweight$40.00 ➝ $44.00Low
i
6/19/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$53.00Low
i
5/10/2019BTIG ResearchReiterated RatingBuy$44.00Medium
i
4/29/2019BTIG ResearchReiterated RatingBuy$44.00Medium
i
3/8/2019BTIG ResearchBoost Price TargetBuy$44.00Low
i
2/20/2019JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$44.00Medium
i
1/2/2019BTIG ResearchBoost Price TargetTop Pick ➝ Buy$37.00Low
i
7/5/2018Piper Jaffray CompaniesBoost Price TargetOverweight$24.00 ➝ $30.00High
i
6/27/2018William BlairReiterated RatingOutperformHigh
i
Rating by M. Kaczor at William Blair
1/5/2018BTIG ResearchReiterated RatingBuy$24.00Medium
i
11/6/2017William BlairInitiated CoverageOutperform ➝ OutperformN/A
i
Rating by K. Krum at William Blair
11/6/2017Stifel NicolausInitiated CoverageBuy ➝ Buy$23.00N/A
i
11/6/2017BTIG ResearchInitiated CoverageBuy ➝ Buy$24.00N/A
i
11/6/2017Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$24.00N/A
i
(Data available from 4/17/2016 forward)
OrthoPediatrics logo
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Read More

Today's Range

Now: $51.30
$50.49
$52.24

50 Day Range

MA: $49.23
$44.26
$55.80

52 Week Range

Now: $51.30
$38.01
$57.42

Volume

70,103 shs

Average Volume

200,674 shs

Market Capitalization

$1.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.67

Frequently Asked Questions

What sell-side analysts currently cover shares of OrthoPediatrics?

The following Wall Street research analysts have issued stock ratings on OrthoPediatrics in the last year: BTIG Research, JMP Securities, Needham & Company LLC, Piper Sandler, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for KIDS.

What is the current price target for OrthoPediatrics?

5 Wall Street analysts have set twelve-month price targets for OrthoPediatrics in the last year. Their average twelve-month price target is $55.80, suggesting a possible upside of 8.8%. Piper Sandler has the highest price target set, predicting KIDS will reach $62.00 in the next twelve months. JMP Securities has the lowest price target set, forecasting a price of $48.00 for OrthoPediatrics in the next year.
View the latest price targets for KIDS.

What is the current consensus analyst rating for OrthoPediatrics?

OrthoPediatrics currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KIDS will outperform the market and that investors should add to their positions of OrthoPediatrics.
View the latest ratings for KIDS.

What other companies compete with OrthoPediatrics?

How do I contact OrthoPediatrics' investor relations team?

OrthoPediatrics' physical mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company's listed phone number is 574-268-6379 and its investor relations email address is [email protected] The official website for OrthoPediatrics is www.orthopediatrics.com.